{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T13:27:46Z","timestamp":1795008466562,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T00:00:00Z","timestamp":1551657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T00:00:00Z","timestamp":1551657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Diffuse intrinsic pontine glioma (DIPG) is an incurable pediatric brain tumor, with approximately 25% of DIPGs harboring activating <jats:italic>ACVR1<\/jats:italic> mutations that commonly co-associate with H3.1K27M mutations. Here we show that in vitro expression of <jats:italic>ACVR1<\/jats:italic> R206H with and without H3.1K27M upregulates mesenchymal markers and activates Stat3 signaling. In vivo expression of <jats:italic>ACVR1<\/jats:italic> R206H or G328V with H3.1K27M and p53 deletion induces glioma-like lesions but is not sufficient for full gliomagenesis. However, in combination with PDGFA signaling, <jats:italic>ACVR1<\/jats:italic> R206H and H3.1K27M significantly decrease survival and increase tumor incidence. Treatment of <jats:italic>ACVR1<\/jats:italic> R206H mutant DIPGs with exogenous Noggin or the <jats:italic>ACVR1<\/jats:italic> inhibitor LDN212854 significantly prolongs survival, with human <jats:italic>ACVR1<\/jats:italic> mutant DIPG cell lines also being sensitive to LDN212854 treatment. Together, our results demonstrate that <jats:italic>ACVR1<\/jats:italic> R206H and H3.1K27M promote tumor initiation, accelerate gliomagenesis, promote a mesenchymal profile partly due to Stat3 activation, and identify LDN212854 as a promising compound to treat DIPG.<\/jats:p>","DOI":"10.1038\/s41467-019-08823-9","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T11:03:46Z","timestamp":1551697426000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":119,"title":["ACVR1 R206H cooperates with H3.1K27M in promoting diffuse intrinsic pontine glioma pathogenesis"],"prefix":"10.1038","volume":"10","author":[{"given":"Christine M.","family":"Hoeman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Cordero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Misuraca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan M.","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herminio J.","family":"Cardona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Nazarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rintaro","family":"Hashizume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"McLendon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Procissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Gadd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oren J.","family":"Becher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,4]]},"reference":[{"key":"8823_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0360-3016(97)00572-5","volume":"40","author":"CR Freeman","year":"1998","unstructured":"Freeman, C. R. & Farmer, J. P. Pediatric brain stem gliomas: a review. Int. J. Radiat. Oncol. Biol. Phys. 40, 265\u2013271 (1998).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"8823_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/pr.2013.194","volume":"75","author":"KM Schroeder","year":"2014","unstructured":"Schroeder, K. M., Hoeman, C. M. & Becher, O. J. Children are not just little adults: recent advances in understanding of diffuse intrinsic pontine glioma biology. Pediatr. Res. 75, 205\u2013209 (2014).","journal-title":"Pediatr. Res."},{"key":"8823_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1470-2045(06)70615-5","volume":"7","author":"D Hargrave","year":"2006","unstructured":"Hargrave, D., Bartels, U. & Bouffet, E. Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol. 7, 241\u2013248 (2006).","journal-title":"Lancet Oncol."},{"key":"8823_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ng.1102","volume":"44","author":"G Wu","year":"2012","unstructured":"Wu, G. et al. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat. Genet. 44, 251\u2013253 (2012).","journal-title":"Nat. Genet."},{"key":"8823_CR5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature10833","volume":"482","author":"J Schwartzentruber","year":"2012","unstructured":"Schwartzentruber, J. et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482, 226\u2013231 (2012).","journal-title":"Nature"},{"key":"8823_CR6","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/ng.2936","volume":"46","author":"P Buczkowicz","year":"2014","unstructured":"Buczkowicz, P. et al. Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nat. Genet. 46, 451\u2013456 (2014).","journal-title":"Nat. Genet."},{"key":"8823_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","volume":"124","author":"DA Khuong-Quang","year":"2012","unstructured":"Khuong-Quang, D. A. et al. K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol. 124, 439\u2013447 (2012).","journal-title":"Acta Neuropathol."},{"key":"8823_CR8","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1101\/gad.217778.113","volume":"27","author":"KM Chan","year":"2013","unstructured":"Chan, K. M. et al. The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression. Genes Dev. 27, 985\u2013990 (2013).","journal-title":"Genes Dev."},{"key":"8823_CR9","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1126\/science.1232245","volume":"340","author":"PW Lewis","year":"2013","unstructured":"Lewis, P. W. et al. Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science 340, 857\u2013861 (2013).","journal-title":"Science"},{"key":"8823_CR10","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ccr.2013.10.006","volume":"24","author":"S Bender","year":"2013","unstructured":"Bender, S. et al. Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas. Cancer Cell 24, 660\u2013672 (2013).","journal-title":"Cancer Cell"},{"key":"8823_CR11","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/bpa.12042","volume":"23","author":"S Venneti","year":"2013","unstructured":"Venneti, S. et al. Evaluation of histone 3 lysine 27 trimethylation (H3K27me3) and enhancer of Zest 2 (EZH2) in pediatric glial and glioneuronal tumors shows decreased H3K27me3 in H3F3A K27M mutant glioblastomas. Brain Pathol. 23, 558\u2013564 (2013).","journal-title":"Brain Pathol."},{"key":"8823_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2012.08.024","volume":"22","author":"D Sturm","year":"2012","unstructured":"Sturm, D. et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22, 425\u2013437 (2012).","journal-title":"Cancer Cell"},{"key":"8823_CR13","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/ng.2950","volume":"46","author":"AM Fontebasso","year":"2014","unstructured":"Fontebasso, A. M. et al. Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma. Nat. Genet. 46, 462\u2013466 (2014).","journal-title":"Nat. Genet."},{"key":"8823_CR14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/ng.2925","volume":"46","author":"KR Taylor","year":"2014","unstructured":"Taylor, K. R. et al. Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma. Nat. Genet. 46, 457\u2013461 (2014).","journal-title":"Nat. Genet."},{"key":"8823_CR15","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/ng.2938","volume":"46","author":"G Wu","year":"2014","unstructured":"Wu, G. et al. The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat. Genet. 46, 444\u2013450 (2014).","journal-title":"Nat. Genet."},{"key":"8823_CR16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/ng1783","volume":"38","author":"EM Shore","year":"2006","unstructured":"Shore, E. M. et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat. Genet. 38, 525\u2013527 (2006).","journal-title":"Nat. Genet."},{"key":"8823_CR17","doi-asserted-by":"publisher","first-page":"366ra163","DOI":"10.1126\/scitranslmed.aaf1090","volume":"8","author":"D Dey","year":"2016","unstructured":"Dey, D. et al. Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossification. Sci. Transl. Med. 8, 366ra163 (2016).","journal-title":"Sci. Transl. Med."},{"key":"8823_CR18","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nature08712","volume":"463","author":"MS Carro","year":"2010","unstructured":"Carro, M. S. et al. The transcriptional network for mesenchymal transformation of brain tumours. Nature 463, 318\u2013325 (2010).","journal-title":"Nature"},{"key":"8823_CR19","doi-asserted-by":"publisher","first-page":"303ra137","DOI":"10.1126\/scitranslmed.aac4358","volume":"7","author":"SJ Hatsell","year":"2015","unstructured":"Hatsell, S. J. et al. ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A. Sci. Transl. Med. 7, 303ra137 (2015).","journal-title":"Sci. Transl. Med."},{"key":"8823_CR20","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1097\/PAS.0b013e318294e817","volume":"37","author":"LY Ballester","year":"2013","unstructured":"Ballester, L. Y. et al. Morphologic characteristics and immunohistochemical profile of diffuse intrinsic pontine gliomas. Am. J. Surg. Pathol. 37, 1357\u20131364 (2013).","journal-title":"Am. J. Surg. Pathol."},{"key":"8823_CR21","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00401-015-1478-0","volume":"130","author":"D Castel","year":"2015","unstructured":"Castel, D. et al. Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol. 130, 815\u2013827 (2015).","journal-title":"Acta Neuropathol."},{"key":"8823_CR22","doi-asserted-by":"publisher","first-page":"e30313","DOI":"10.1371\/journal.pone.0030313","volume":"7","author":"S Puget","year":"2012","unstructured":"Puget, S. et al. Mesenchymal transition and PDGFRA amplification\/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas. PLoS One 7, e30313 (2012).","journal-title":"PLoS One"},{"key":"8823_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40478-018-0553-x","volume":"6","author":"GL Lin","year":"2018","unstructured":"Lin, G. L. et al. Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma. Acta Neuropathol. Commun. 6, 51 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"8823_CR24","doi-asserted-by":"publisher","first-page":"52543","DOI":"10.18632\/oncotarget.15002","volume":"8","author":"A Plessier","year":"2017","unstructured":"Plessier, A. et al. New in vivo avatars of diffuse intrinsic pontine gliomas (DIPG) from stereotactic biopsies performed at diagnosis. Oncotarget 8, 52543\u201352559 (2017).","journal-title":"Oncotarget"},{"key":"8823_CR25","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1126\/science.1253799","volume":"346","author":"K Funato","year":"2014","unstructured":"Funato, K., Major, T., Lewis, P. W., Allis, C. D. & Tabar, V. Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation. Science 346, 1529\u20131533 (2014).","journal-title":"Science"},{"key":"8823_CR26","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ccell.2017.09.014","volume":"32","author":"M Pathania","year":"2017","unstructured":"Pathania, M. et al. H3.3(K27M) cooperates with Trp53 loss and PDGFRA gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas. Cancer Cell 32, 684\u2013700 (2017).","journal-title":"Cancer Cell"},{"key":"8823_CR27","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/44334","volume":"401","author":"D Lyden","year":"1999","unstructured":"Lyden, D. et al. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401, 670\u2013677 (1999).","journal-title":"Nature"},{"key":"8823_CR28","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.neuron.2017.10.008","volume":"96","author":"MA Petersen","year":"2017","unstructured":"Petersen, M. A. et al. Fibrinogen activates BMP signaling in oligodendrocyte progenitor cells and inhibits remyelination after vascular damage. Neuron 96, 1003\u20131012 (2017).","journal-title":"Neuron"},{"key":"8823_CR29","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/NEN.0000000000000216","volume":"74","author":"IC Taylor","year":"2015","unstructured":"Taylor, I. C. et al. Disrupting NOTCH slows diffuse intrinsic pontine glioma growth, enhances radiation sensitivity, and shows combinatorial efficacy with bromodomain inhibition. J. Neuropathol. Exp. Neurol. 74, 778\u2013790 (2015).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"8823_CR30","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1021\/cb300655w","volume":"8","author":"AH Mohedas","year":"2013","unstructured":"Mohedas, A. H. et al. Development of an ALK2-biased BMP type I receptor kinase inhibitor. ACS Chem. Biol. 8, 1291\u20131302 (2013).","journal-title":"ACS Chem. Biol."},{"key":"8823_CR31","doi-asserted-by":"publisher","first-page":"7900","DOI":"10.1021\/jm501177w","volume":"57","author":"AH Mohedas","year":"2014","unstructured":"Mohedas, A. H. et al. Structure\u2013activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants. J. Med. Chem. 57, 7900\u20137915 (2014).","journal-title":"J. Med. Chem."},{"key":"8823_CR32","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nature05349","volume":"444","author":"SG Piccirillo","year":"2006","unstructured":"Piccirillo, S. G. et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444, 761\u2013765 (2006).","journal-title":"Nature"},{"key":"8823_CR33","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1093\/neuonc\/nov310","volume":"18","author":"LD Hover","year":"2016","unstructured":"Hover, L. D. et al. Bone morphogenetic protein signaling promotes tumorigenesis in a murine model of high-grade glioma. Neuro Oncol. 18, 928\u2013938 (2016).","journal-title":"Neuro Oncol."},{"key":"8823_CR34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ccr.2007.12.005","volume":"13","author":"J Lee","year":"2008","unstructured":"Lee, J. et al. Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell 13, 69\u201380 (2008).","journal-title":"Cancer Cell"},{"key":"8823_CR35","first-page":"699","volume":"19","author":"CN Kline","year":"2017","unstructured":"Kline, C. N. et al. Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy. Neuro Oncol. 19, 699\u2013709 (2017).","journal-title":"Neuro Oncol."},{"key":"8823_CR36","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.stem.2014.01.005","volume":"14","author":"A Pietras","year":"2014","unstructured":"Pietras, A. et al. Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth. Cell Stem Cell 14, 357\u2013369 (2014).","journal-title":"Cell Stem Cell"},{"key":"8823_CR37","doi-asserted-by":"publisher","first-page":"5360","DOI":"10.1158\/0008-5472.CAN-17-1294","volume":"77","author":"KH Chow","year":"2017","unstructured":"Chow, K. H. et al. S100A4 is a biomarker and regulator of glioma stem cells that is critical for mesenchymal transition in glioblastoma. Cancer Res. 77, 5360\u20135373 (2017).","journal-title":"Cancer Res."},{"key":"8823_CR38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ccr.2006.02.019","volume":"9","author":"HS Phillips","year":"2006","unstructured":"Phillips, H. S. et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9, 157\u2013173 (2006).","journal-title":"Cancer Cell"},{"key":"8823_CR39","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1158\/1541-7786.MCR-13-0349","volume":"12","author":"M Srikanth","year":"2014","unstructured":"Srikanth, M., Kim, J., Das, S. & Kessler, J. A. BMP signaling induces astrocytic differentiation of clinically derived oligodendroglioma propagating cells. Mol. Cancer Res. 12, 283\u2013294 (2014).","journal-title":"Mol. Cancer Res."},{"key":"8823_CR40","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1126\/science.1226929","volume":"338","author":"D Friedmann-Morvinski","year":"2012","unstructured":"Friedmann-Morvinski, D. et al. Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice. Science 338, 1080\u20131084 (2012).","journal-title":"Science"},{"key":"8823_CR41","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ccr.2014.06.005","volume":"26","author":"T Ozawa","year":"2014","unstructured":"Ozawa, T. et al. Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma. Cancer Cell 26, 288\u2013300 (2014).","journal-title":"Cancer Cell"},{"key":"8823_CR42","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RG Verhaak","year":"2010","unstructured":"Verhaak, R. G. et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17, 98\u2013110 (2010).","journal-title":"Cancer Cell"},{"key":"8823_CR43","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1002\/glia.23203","volume":"65","author":"CJ Herting","year":"2017","unstructured":"Herting, C. J. et al. Genetic driver mutations define the expression signature and microenvironmental composition of high-grade gliomas. Glia 65, 1914\u20131926 (2017).","journal-title":"Glia"},{"key":"8823_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-155","volume":"11","author":"R Duggal","year":"2013","unstructured":"Duggal, R. et al. Vaccinia virus expressing bone morphogenetic protein-4 in novel glioblastoma orthotopic models facilitates enhanced tumor regression and long-term survival. J. Transl. Med. 11, 155 (2013).","journal-title":"J. Transl. Med."},{"key":"8823_CR45","doi-asserted-by":"publisher","first-page":"e77639","DOI":"10.1371\/journal.pone.0077639","volume":"8","author":"KL Barton","year":"2013","unstructured":"Barton, K. L. et al. PD-0332991, a CDK4\/6 inhibitor, significantly prolongs survival in a genetically engineered mouse model of brainstem glioma. PLoS One 8, e77639 (2013).","journal-title":"PLoS One"},{"key":"8823_CR46","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s40478-014-0134-6","volume":"2","author":"KL Misuraca","year":"2014","unstructured":"Misuraca, K. L. et al. Pax3 expression enhances PDGF-B-induced brainstem gliomagenesis and characterizes a subset of brainstem glioma. Acta Neuropathol. Commun. 2, 134 (2014).","journal-title":"Acta Neuropathol. Commun."},{"key":"8823_CR47","doi-asserted-by":"publisher","first-page":"W3","DOI":"10.1093\/nar\/gkw343","volume":"44","author":"E Afgan","year":"2016","unstructured":"Afgan, E. et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update. Nucleic Acids Res. 44, W3\u2013W10 (2016).","journal-title":"Nucleic Acids Res."},{"key":"8823_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"8823_CR49","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nm.3855","volume":"21","author":"CS Grasso","year":"2015","unstructured":"Grasso, C. S. et al. Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nat. Med. 21, 555\u2013559 (2015).","journal-title":"Nat. Med."},{"key":"8823_CR50","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11060-012-0973-6","volume":"110","author":"R Hashizume","year":"2012","unstructured":"Hashizume, R. et al. Characterization of a diffuse intrinsic pontine glioma cell line: implications for future investigations and treatment. J. Neurooncol. 110, 305\u2013313 (2012).","journal-title":"J. Neurooncol."},{"key":"8823_CR51","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nm.4293","volume":"23","author":"F Mohammad","year":"2017","unstructured":"Mohammad, F. et al. EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas. Nat. Med. 23, 483\u2013492 (2017).","journal-title":"Nat. Med."},{"key":"8823_CR52","doi-asserted-by":"publisher","first-page":"e0169485","DOI":"10.1371\/journal.pone.0169485","volume":"12","author":"T Hennika","year":"2017","unstructured":"Hennika, T. et al. Pre-clinical study of panobinostat in xenograft and genetically engineered murine diffuse intrinsic pontine glioma models. PLoS One 12, e0169485 (2017).","journal-title":"PLoS One"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-08823-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-08823-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-08823-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T21:08:59Z","timestamp":1671224939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-08823-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,4]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["8823"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-08823-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,4]]},"assertion":[{"value":"28 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1023"}}